TCG Advisors’s GSK GSK Stock Holding History

TCG Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-82	Closed	-$4K	–	236
2019 Q2	$4K	Buy	82 +2	+3%	+$100	﹤0.01%	350
2019 Q1	$4K	Buy	+80	New	+$4K	﹤0.01%	347

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

TCG Advisors's GSK Position: Q3 2019 in Review

TCG Advisors sold out of GSK (GSK) in Q3 2019, closing a stake of 82 shares — an estimated $4K sold.

TCG Advisors first reported a position in GSK in Q1 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

TCG Advisors reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 82 GSK shares in Q3 2019, an estimated $4K.
TCG Advisors first reported a position in GSK in Q1 2019 and held it in 2 quarters.
TCG Advisors's GSK position peaked at $4K in Q2 2019.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.